BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs2476601
,
MDM2
,
Fatty acid metabolic process
,
HIV infection
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
zibotentan
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect o…
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study d…
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-co…
Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microva…
Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintai…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
Zibotentan Better Renal Scleroderma Outcome Study
10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies
A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Ren…
Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ